MedPath

Comparison of DNA in tissues in cervix cancer with tissues of tumour adjacent normal cervix tissue to study and identify differences in both on genetic level

Not Applicable
Conditions
Health Condition 1: C53- Malignant neoplasm of cervix uteri
Registration Number
CTRI/2021/12/038514
Lead Sponsor
MHRDUAY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Histologically confirmed Cervical Carcinoma

2)Treatment naive

3)Tumour and adjacent normal tissue sample preserved byTMH/ACTREC Tumour Tissue Repository

4)Patient consented for study by TMH/ACTREC Tumour Tissue repository Repository

Exclusion Criteria

1)Patients who have received any form of prior treatment

2)Patients not consented by TMH/ACTREC Tumour Tissue Repository

3)Patients whose clinical history is not available

4)Patients for whom paired normal tissue or blood is not collected

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath